Sort
85,873 grants matching “alzheimers”
The Role of Ubiquitination in Tau Oligomers Pathogenesis
$748,330Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2023 · AG
The Role of Ubiquitination in Tau Oligomers Pathogenesis
$748,330Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2024 · AG
The Role of Ubiquitination in Tau Oligomers Pathogenesis
$748,330Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2022 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
$748,297Emily J Rogalski · Northwestern University At Chicago · R01 · FY2021 · AG
Search for the Alzheimer's Gene on Chromosome 10
$748,287M. Ilyas Kamboh · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AG
RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (Rest)
$748,283Barry David Greenberg · Johns Hopkins University · R01 · FY2022 · AG
Core D: Neuropathology
$748,276Richard Justin Perrin · Washington University · P30 · FY2023 · AG
Elucidating the Roles of Transposable Elements in Alzheimer's and related dementias
$748,271Peng Jin · Emory University · R01 · FY2024 · AG
Deep-Learning Enhanced ASL MRI For Early AD Assessment
$748,215Ze Wang · University Of Maryland Baltimore · R01 · FY2025 · AG
EFFECTS OF ALZHEIMER'S DISEASE IN THE PREDIAGNOSIS PERIOD ON FINANCIAL OUTCOMES
$748,180The Rand Corporation · · FY2016 · Department of the Army
PERSEVERE in Lewy Body Dementia: A Randomized, Controlled Trial of Peer Mentor Support and Caregiver Education
$748,170Jori Erin Fleisher · Rush University Medical Center · R01 · FY2025 · AG
Gut barrier function in Alzheimerâs disease
$748,156Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2022 · AG
Genetic Modifiers of TREM2 in Alzheimer's Disease
$748,145Carlos Cruchaga · Washington University · R01 · FY2024 · AG
Roles of reticulon proteins in neurodegenerative disorders
$748,128Riqiang Yan · University Of Connecticut Sch Of Med/Dnt · R01 · FY2024 · AG
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
$748,092Mark W Albers · Massachusetts General Hospital · R01 · FY2021 · AG
Effects of Healthy Aging and Mild Cognitive Impairment on Memory Representations
$748,031Roberto Cabeza · Duke University · R01 · FY2025 · AG
1/2 Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development
$747,973Nenad Sestan · Yale University · U01 · FY2022 · MH
Cellular and Genetic Origins of Astrocytes
$747,957David H Rowitch · University Of California, San Francisco · R01 · FY2011 · NS
Characterizing the evolution of Subjective Cognitive Decline in preclinical Alzheimer's disease
$747,953Rebecca E Amariglio · Brigham And Women'S Hospital · R01 · FY2024 · AG
Michigan Center on the Demography of Aging
$747,924Vicki A. Freedman · University Of Michigan At Ann Arbor · P30 · FY2020 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
$747,866Emily J Rogalski · University Of Chicago · R01 · FY2023 · AG
Progressing the Pre-clinical development of P8 for Alzheimer's Disease
$747,850Nazneen N Dewji · Cenna Biosciences, Inc. · R44 · FY2018 · AG
Creating a region- specific biomolecular atlas of the brain of Alzheimerâs disease
$747,773Lingjun Li · University Of Wisconsin-Madison · R01 · FY2024 · AG
3D Reconstruction and Analysis of Alzheimer's Patient Biopsy Samples to Map and Quantify Hallmarks of Pathogenesis and Vulnerability
$747,767Mark H Ellisman · University Of California, San Diego · R01 · FY2021 · AG
Deciphering molecular mechanisms that underlie brain endothelial cell dysfunction with APOE4
$747,743Leon Maing Tai · University Of Illinois At Chicago · R01 · FY2024 · AG